Stability evaluation of H3N2 influenza split vaccine in drying process for solidification

Purpose Currently, most vaccines have been manufactured in liquid forms that are needed a cold-chain system. However, this system does not guarantee the stability of vaccines always and requires a high cost. Although solidification of vaccine can be alternative, vaccine stability is a problem. Recen...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical investigation Vol. 50; no. 1; pp. 107 - 113
Main Authors: Kim, Sung-Jin, Na, Young-Guk, Lee, Hong-Ki, Lee, Hye-Jin, Wang, Miao, Huh, Hyun Wook, Lee, Han-Sol, Lee, Jae-Young, Cho, Cheong-Weon
Format: Journal Article
Language:English
Published: Singapore Springer Singapore 2020
한국약제학회
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Currently, most vaccines have been manufactured in liquid forms that are needed a cold-chain system. However, this system does not guarantee the stability of vaccines always and requires a high cost. Although solidification of vaccine can be alternative, vaccine stability is a problem. Recently, influenza vaccine delivery using microneedle formulation has been studied extensively. Moreover, the stability of the vaccine can be improved since the vaccine is solid form in the microneedle. Therefore, the aim of this study is to screen the suitable stabilizer in the drying process and to compare evaluation methods for H3N2 split vaccine stability. Methods Dried vaccine samples were evaluated by enzyme-linked immunosorbent assay (ELISA), sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and circular dichroism (CD). Results Fructose provided stability to the vaccine during the drying process by ELISA (91.1 ± 8.9%) and SDS-PAGE (about 65%). Trehalose was rated as providing stability to the vaccine when evaluated with ELISA and SDS-PAGE but was not when evaluated with CD. Conclusions The stability of the vaccine should be finally determined by comprehensively evaluating the structure and antigenicity of various proteins.
ISSN:2093-5552
2093-6214
DOI:10.1007/s40005-019-00437-z